Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explore the Primary Resistance Mechanisms of Anaplastic Lymphoma Kinase Inhibitors

NCT07045610 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07045610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07045610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explore the Primary Resistance Mechanisms of Anaplastic Lymphoma Kinase Inhibitors
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk-positive advanced nsclc patients, ngs, primary resistance